Journal
EXPERIMENTAL CELL RESEARCH
Volume 345, Issue 1, Pages 93-99Publisher
ELSEVIER INC
DOI: 10.1016/j.yexcr.2016.05.013
Keywords
MiR-21; TGF-beta 1; Smad7; Hypertrophic scar; Fibrosis
Categories
Funding
- National Natural Science Foundation of China [81201204]
Ask authors/readers for more resources
Hypertrophic scar (HS) is a fibroproliferative disorder caused by abnormal wound healing, which is characterized by excessive deposition of extracellular matrix (ECM) secreted by fibroblasts. We previous have found that expression of microRNA-21(miR-21) was increased in tissues and fibroblasts of HS. However, the underlying molecular mechanism remains to be further elucidated. In this study, we identified the miR-21 was a marker for the phenotype of HS fibroblasts, as anti-miR-21 reduced expression of fibrosis markers such as Col1A1, Col3A1, Fn and alpha-SMA in fibroblasts and overexpression of miR-21 promoted fibroproliferative expression in fibroblasts. Furthermore, we also found that miR-21 promoted TGF-beta 1 induced fibroproliferative expression by repressing Smad7 expression in vitro. In addition, the miR-21 inhibitor inhibited the growth of hypertrophic scar tissue in vivo (nude mice experimental model). These results indicated that miR-21 was a critical regulator for HS formation and TGF-beta 1/rniR-21/Smad7 pathway could be a useful therapeutic target for the treatment of HS. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available